Skip to main content
logo
BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.6994
+0.0046 (0.66%)
At close: Oct 31, 2025, 4:00 PM EST
0.7203
+0.0209 (2.99%)
Pre-market: Nov 3, 2025, 7:00 AM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '21 Dec '20 Dec '19 Dec '18
Antibody-based Products
11.00M
Log In
Log In
Log In
Log In
Antibody-based Products Growth
4300.00%
Log In
Log In
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '21 Dec '20 Dec '19 Dec '18
United States
11.00M
Log In
Log In
Log In
Log In
United States Growth
4300.00%
Log In
Log In
Log In
Log In